Comparative analysis of cytokine gene expression in cerebrospinal fluid of horses without neurologic signs or with selected neurologic disorders

American Journal of Veterinary Research

Volumn 67, Issue 8, 2006, Pages 1433-1437

  Pusterla, Nicola ^a   Wilson, David ^a   Conrad, Patricia A ^a   Mapes, Samantha ^a   Leutenegger, Christian M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPROTOZOAL AGENT; COMPLEMENTARY DNA; CYTOKINE; FLUNIXIN MEGLUMINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 6; INTERLEUKIN 8; PONAZURIL; RNA; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL NUCLEUS; CEREBROSPINAL FLUID; CERVICAL MYELOPATHY; CONTROLLED STUDY; ENCEPHALITIS; ENCEPHALOMYELITIS; ERYTHROCYTE; GENETIC TRANSCRIPTION; HORSE DISEASE; NEUROLOGIC DISEASE; NONHUMAN; PROTEIN CEREBROSPINAL FLUID LEVEL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RNA EXTRACTION; SPINAL CORD INJURY;

ANIMALS; CENTRAL NERVOUS SYSTEM PROTOZOAL INFECTIONS; CERVICAL VERTEBRAE; CYTOKINES; GENE EXPRESSION PROFILING; HORSE DISEASES; HORSES; NERVOUS SYSTEM DISEASES; SPINAL CORD DISEASES; SPINAL CORD INJURIES; WEST NILE FEVER;

ANIMALIA; EQUIDAE; WEST NILE VIRUS;

EID: 33747807628     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.67.8.1433     Document Type: Article

References (32)

1. Weller M, Stevens A, Sommer N, et al. Comparative analysis of cytokine patterns in immunological, infectious, and oncological neurological disorders. J Neurol Sci 1991;104:215-221.
2. Azuma H, Makita Y, Araki A, et al. Elevated interleukin 6 without pleocytosis in cerebrospinal fluid in encephalitis patients. Eur J Pediatr 1997;156:507-508.
3. Sherwood ER, Prough DS. Interleukin-8, neuroinflammation, and secondary brain injury. Crit Care Med 2000;28:1221-1223.
4. Tang RB, Lee BH, Chung RL, et al. Interleukin-1β and tumor necrosis factor-α in cerebrospinal fluid of children with bacterial meningitis. Childs Nerv Syst 2001;17:453-456.
5. Karpus WJ. Chemokines and central nervous system disorders. J Neurovirol 2001;7:493-500.
6. Hackett SJ, Thomson AP, Hart CA. Cytokines, chemokines and other effector molecules involved in meningococcal disease. J Med Microbiol 2001;50:847-859.
7. Hausfater P, Fillet AM, Rozenberg F, et al. Prevalence of viral infection markers by polymerase chain reaction amplification and interferon-α measurements among patients undergoing lumbar puncture in an emergency department. J Med Virol 2004;73:137-146.
8. Ossege LM, Voss B, Wiethege T, et al. Detection of transforming growth factor-β1 mRNA in cerebrospinal fluid cells of patients with meningitis by non-radioactive in situ hybridization. J Neurol 1994; 242:14-19.
9. Renno T, Lin JY, Piccirillo C, et al. Cytokine production by cells in cerebrospinal fluid during experimental allergic encephalomyelitis in SJL/J mice. J Neuroimmunol 1994;49:1-7.
10. Rieckmann P, Albrecht M, Ehrenreich H, et al. Semi-quantitative analysis of cytokine gene expression in blood and cerebrospinal fluid cells by reverse transcriptase polymerase chain reaction. Res Exp Med (Berl) 1995;195:17-29.
11. Ossege LM, Sindern E, Voss B, et al. Expression of tumor necrosis factor-α and transforming growth factor-β1 in cerebrospinal fluid cells in meningitis. J Neurol Sci 1996;144:1-13.
12. Frisk AL, Baumgartner W, Grone A. Dominating interleukin-10 mRNA expression induction in cerebrospinal fluid cells of dogs with natural canine distemper virus induced demyelinating and non-demyelinating CNS lesions. J Neuroimmunol 1999;97:102-109.
13. Ossege LM, Sindern E, Voss B, et al. Expression of TNFα and TGFβ1 in Guillain-Barre syndrome: correlation of a low TNFα- /TGFβ1-mRNA ratio with good recovery and signs for immunoregulation within the cerebrospinal fluid compartment. Eur J Neurol 2000;7:17-25.
14. Vitarbo EA, Chatzipanteli K, Kinoshita K, et al. Tumor necrosis factor α expression and protein levels after fluid percussion injury in rats: the effect of injury severity and brain temperature. Neurosurgery 2004;55:416-424.
15. Leutenegger CM, von Rechenberg B, Huder JB, et al. Quantitative real-time PCR for equine cytokine mRNA in nondecalcified bone tissue embedded in methyl methacrylate. Calcif Tissue Int 1999;65:378-383.
16. Colahan PT, Kollias-Baker TC, Leutenegger CM, et al. Does training affect mRNA transciption for cytokine production in circulating leucocytes? Equine Vet J 2002;34:154-158.
17. Leutenegger CM, Mislin CN, Sigrist B, et al. Quantitative real-time PCR for the measurement of feline cytokine mRNA. Vet Immunol Immunopathol 1999;71:291-305.
18. Mayhew IG, Whitlock RH, Tasker JB. Equine cerebrospinal fluid: reference values of normal horses. Am J Vet Res 1977;38:1271-1274.
19. Sharief MK, McLean B, Thompson EJ. Elevated serum levels of tumor necrosis factor-α in Guillain-Barre syndrome. Ann Neurol 1993;33:591-596.
20. Sivieri S, Ferrarini AM, Lolli F, et al. Cytokine pattern in the cerebrospinal fluid from patients with GBS and CIDP. J Neurol Sci 1997;147:93-95.
21. Banks WA, Kastin AJ, Broadwell RD. Passage of cytokines across the blood-brain barrier. Neuroimmunomodulation 1995; 2:241-248.
22. Vitkovic L, Bockaert J, Jacque C. Inflammatory cytokines: neuromodulators in normal brain. J Neurochem 2000;74:457-471.
23. Halstensen A, Ceska M, Brandtzaeg P, et al. Interleukin-8 in serum and cerebrospinal fluid from patients with meningococcal disease. J Infect Dis 1993;167:471-475.
24. Lopez-Cortes LF, Cruz-Ruiz M, Gomez-Mateos J, et al. Interleukin-8 in cerebrospinal fluid from patients with meningitis of different etiologies: its possible role as neutrophil chemotactic factor. J Infect Dis 1995;172:581-584.
25. Narita M, Tanaka H, Togashi T. Cytokines involved in CNS manifestations caused by Mycoplasma pneumoniae. Pediatr Neurol 2005;33:105-109.
26. Wong ML, Rettori V, Al-Shekhlee A, et al. Inducible nitric oxide synthase gene expression in the brain during systemic inflammation. Nat Med 1996;2:581-584.
27. Perrin FE, Lacroix S, Aviles-Trigueros M, et al. Involvement of monocyte chemoattractant protein-1, macrophage inflammatory protein-1α and interleukin-1β in Wallerian degeneration. Brain 2005;128:854-866.
28. Hunter CA, Roberts CW, Alexander J. Kinetics of cytokine mRNA production in the brains of mice with progressive toxoplasmic encephalitis. Eur J Immunol 1992;22:2317-2322.
29. Fischer HG, Nitzgen B, Reichmann G, et al. Cytokine responses induced by Toxoplasma gondii in astrocytes and microglial cells. Eur J Immunol 1997;27:1539-1548.
30. Bitsch A, Trostdorf F, Bruck W, et al. Central nervous system TNFα-mRNA expression during rabbit experimental pneumococcal meningitis. Neurosci Lett 1997;237:105-108.
31. Dietrich WD, Chatzipanteli K, Vitarbo E, et al. The role of inflammatory processes in the pathophysiology and treatment of brain and spinal cord trauma. Acta Neurochir Suppl 2004;89:69-74.
32. Wu KL, Chan SH, Chao YM, et al. Expression of pro-inflammatory cytokine and caspase genes promotes neuronal apoptosis in pontine reticular formation after spinal cord transection. Neurobiol Dis 2003;14:19-31.